Patents by Inventor Alexander Drew

Alexander Drew has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240071257
    Abstract: A surgeon training apparatus includes a cassette, which includes biological tissue repurposed into a form consistent with the anatomical configuration of abdominal hernias, affixed into an anatomically correct silicon framework which replicates the abdominal anatomy. The framework positions the cassette in an anatomically correct position within the abdominal cavity, enabling surgeons to train using a properly positioned representation of the target anatomy, thus requiring the surgeon to properly use surgical tools to correct the pathologic condition caused by the hernia. The cassette is formed by applying biologic tissue to a specially designed “plate,” which affixes the tissue block into the anatomic framework, and is adapted for connection to a grounding device so the surgeon can use cautery during the simulated hernia repair.
    Type: Application
    Filed: November 7, 2023
    Publication date: February 29, 2024
    Inventors: JOHN ALEXANDER, W. ANDREW GRUBBS, KAITY YU EMERSON, MORGAN DOMINICE MOORE, MEGAN HARRISION DEW, SAMUEL DAVID DREW
  • Publication number: 20180153987
    Abstract: A chimeric fusion polypeptide is provided comprising an extracellular domain of a canine TNF receptor p60 or p80 polypeptide conjoined to an Fc region of a canine IgG immunoglobulin heavy chain. The chimeric fusion polypeptide may be used in the treatment or prevention of conditions in canines mediated by TNF expression.
    Type: Application
    Filed: July 14, 2017
    Publication date: June 7, 2018
    Applicant: NEXVET AUSTRALIA LTD
    Inventors: Alexander DREW, David Gearing
  • Patent number: 9731007
    Abstract: A chimeric fusion polypeptide is provided comprising an extracellular domain of a canine TNF receptor p60 or p80 polypeptide conjoined to an Fc region of a canine IgG immunoglobulin heavy chain. The chimeric fusion polypeptide may be used in the treatment or prevention of conditions in canines mediated by TNF expression.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: August 15, 2017
    Assignee: Nexvet Australia Pty Ltd
    Inventors: Alexander Drew, David Gearing
  • Publication number: 20150037333
    Abstract: A chimeric fusion polypeptide is provided comprising an extracellular domain of a canine TNF receptor p60 or p80 polypeptide conjoined to an Fc region of a canine IgG immunoglobulin heavy chain. The chimeric fusion polypeptide may be used in the treatment or prevention of conditions in canines mediated by TNF expression.
    Type: Application
    Filed: February 22, 2013
    Publication date: February 5, 2015
    Applicant: NVIP Pty Ltd
    Inventors: Alexander Drew, David Gearing